Promising hantavirus vaccine research stalled by funding gap before outbreak
Research on a promising hantavirus vaccine has been delayed due to a lack of funding. This comes in light of renewed global concern following a recent outbreak on a cruise ship. Authorities are preparing quarantine measures in response to the situation.
- ▪Early results for a hantavirus vaccine showed promise but are currently stalled.
- ▪The funding gap has hindered further development of the vaccine.
- ▪A recent outbreak on the cruise ship MV Hondius has raised global concerns about hantavirus.
Opening excerpt (first ~120 words) tap to expand
Promising hantavirus vaccine research stalled by funding gap before outbreak Promising early results have been put on the back burner despite renewed global concern following a deadly cruise ship outbreak. Follow us on GoogleMedics work outside of the cruise ship MV Hondius, which was affected by a hantavirus outbreak, after it arrived at the Port of Rotterdam, where Dutch authorities are preparing quarantine arrangements, in Rotterdam, Netherlands, May 18, 2026.(photo credit: YVES HERMAN/REUTERS)
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Jerusalem Post | JPost.com.